Hcw biologics reports second quarter financial results and recent business highlights

Miramar, fla., aug. 13, 2021 (globe newswire) -- hcw biologics inc. (the “company”) (nasdaq: hcwb), an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended june 30, 2021.
HCWB Ratings Summary
HCWB Quant Ranking